David A. Rosa - 26 May 2021 Form 4 Insider Report for NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)

Role
CEO and President, Director
Signature
/s/ Stephanie Swan, by Power of Attorney
Issuer symbol
NMTC
Transactions as of
26 May 2021
Net transactions value
$0
Form type
4
Filing time
07 Oct 2021, 16:03:36 UTC
Previous filing
09 Sep 2022
Next filing
29 Sep 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NMTC Option to Purchase Common Stock Award $0 +83,333 +25% $0.000000 416,667 26 May 2021 Common Stock 83,333 $5.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 27, 2021, the reporting person was granted an option to purchase shares of common stock, 83,333 shares of which were subject to performance criteria, which performance criteria were met on May 26, 2021, resulting in the vesting of that portion of the option.